Terms ending in 2031
Every in-force patent on Shire LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,697,132 | Capsule and Powder Formulations Containing Lanthanum Compounds In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 9,458,198 | Cyclic peptide-based NPR-B agonists In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,545,837 | Methods and Compositions for CNS Delivery of IDURONATE-2-Sulfatase In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 8,580,922 | Peptide Linkers for Polypeptide Compositions and Methods for Using Same In force · High confidence | Shire Human Genetic Therapies, Inc. | In force | High confidence | |
| US 11,065,307 | Therapeutic Fusion Protein Comprising an Alpha-N-Acetylglucosaminidase and a Lysosomal Targeting Moiety In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 11,065,308 | Methods and Compositions for CNS Delivery of Heparan N-Sulfatase In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 11,260,112 | Methods and Compositions for CNS Delivery of IDURONATE-2-Sulfatase In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 11,471,516 | CNS Delivery of Therapeutic Agents In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 12,121,569 | Methods and Compositions for CNS Delivery of IDURONATE-2-Sulfatase In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 12,409,210 | CNS Delivery of Therapeutic Agents In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| 24 more term ends in 2031 · Pro | |||||
10 of 34 patents shown. Soonest term end first, then patent number.
Pro members see all 34.
8 of these are in force and held by Shire LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.